Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Yong-jiang Hei
Yong-jiang Hei

Zai Lab

Dr. Hei is the CMO at Zai Lab where he oversees the clinical development and portfolio strategy for all the oncology projects.  Prior to Zai Lab, Dr. Hei was the Corporate VP and CMO at Qilu Pharmaceuticals where he led the overall clinical development functions and supported business development and strategic alliances.  Previously, Dr. Hei worked at the San Diego-based biotechnology company Ambrx Inc. for more than 2 years as the CMO responsible for the clinical strategy and operations, focusing on antibody-drug conjugates (ADCs) and CD3-based biospecifics.  Prior to Ambrx, Dr. Hei had worked at Amgen for more than 9 years before joining Ambrx, initially as the Head of Oncology Medical Affairs, and subsequently as an Executive Medical Director in Oncology Global Development in the capacity of a group or project leader for several oncology pipeline molecules and marketed products including the small molecules VEGF inhibitor motesanib and monoclonal antibodies targeting the death receptor DR4/5 (conatumumab) or the EGFR (panitumumab or Vectibix®).  Additionally, during his tenure at Amgen, Dr. Hei built the clinical medical teams for Amgen China in Shanghai and led the product development and clinical operations function for Amgen China.  Before Amgen, Dr. Hei worked for a few years at Novartis oncology as the Senior Global Brand Medical Director/Executive Director leading the clinical development and medical affairs teams for zoledronic acid (Zometa®), and for a few years at Roche Laboratories as the oncology Medical Director supporting capecitabine (Xeloda®) and other oncology projects.